Oxidative stress is implicated in the pathogenesis of non-alcoholic fatty liver disease (NAFLD). In the present study, hepatic and plasma oxidative stress-related parameters were measured and correlated with clinical and histological findings in 31 NAFLD patients showing increased body mass index. Liver protein carbonyl content was enhanced by 403% in patients with steatosis (n=15) compared with control values (n=12), whereas glutathione content, superoxide dismutase (SOD) activity and the ferric reducing ability of plasma (FRAP) were decreased by 57%, 48% and 21% (P<0.05) respectively. No changes in microsomal p-nitrophenol hydroxylation and the total content of cytochrome P450 (CYP) or CYP2E1 were observed. Patients with steatohepatitis (n=16) exhibited protein carbonyl content comparable with that of controls, whereas glutathione content, SOD and catalase activities were decreased by 27%, 64% and 48% (P<0.05). In addition, FRAP values in patients with steatohepatitis were reduced by 33% and 15% (P<0.05) when compared with controls and patients with steatosis respectively, whereas p-nitrophenol hydroxylation (52%) and CYP2E1 content (142%) were significantly increased (P<0.05) compared with controls. It is concluded that oxidative stress is developed in the liver of NAFLD patients with steatosis and is exacerbated further in patients with steatohepatitis, which is associated with CYP2E1 induction. Substantial protein oxidation is followed by proteolysis of the modified proteins, which may explain the co-existence of a diminished antioxidant capacity and protein oxidation in the liver of patients with steatohepatitis.
Skip Nav Destination
Article navigation
Research Article|
March 01 2004
Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients
Luis A. VIDELA;
*Molecular and Clinical Pharmacology Program, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Casilla 70058, Santiago-7, Chile
Correspondence: Professor Luis A. Videla (e-mail [email protected]).
Search for other works by this author on:
Ramón RODRIGO;
Ramón RODRIGO
*Molecular and Clinical Pharmacology Program, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Casilla 70058, Santiago-7, Chile
Search for other works by this author on:
Myriam ORELLANA;
Myriam ORELLANA
*Molecular and Clinical Pharmacology Program, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Casilla 70058, Santiago-7, Chile
Search for other works by this author on:
Virginia FERNANDEZ;
Virginia FERNANDEZ
*Molecular and Clinical Pharmacology Program, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Casilla 70058, Santiago-7, Chile
Search for other works by this author on:
Gladys TAPIA;
Gladys TAPIA
*Molecular and Clinical Pharmacology Program, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Casilla 70058, Santiago-7, Chile
Search for other works by this author on:
Luis QUIÑONES;
Luis QUIÑONES
*Molecular and Clinical Pharmacology Program, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Casilla 70058, Santiago-7, Chile
Search for other works by this author on:
Nelson VARELA;
Nelson VARELA
*Molecular and Clinical Pharmacology Program, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Casilla 70058, Santiago-7, Chile
Search for other works by this author on:
Jorge CONTRERAS;
Jorge CONTRERAS
†Department of Medicine, University of Chile Clinical Hospital, Casilla 70000, Santiago-7, Chile
Search for other works by this author on:
Raúl LAZARTE;
Raúl LAZARTE
†Department of Medicine, University of Chile Clinical Hospital, Casilla 70000, Santiago-7, Chile
Search for other works by this author on:
Attila CSENDES;
Attila CSENDES
‡Department of Surgery, University of Chile Clinical Hospital, Casilla 70000, Santiago-7, Chile
Search for other works by this author on:
Jorge ROJAS;
Jorge ROJAS
‡Department of Surgery, University of Chile Clinical Hospital, Casilla 70000, Santiago-7, Chile
Search for other works by this author on:
Fernando MALUENDA;
Fernando MALUENDA
‡Department of Surgery, University of Chile Clinical Hospital, Casilla 70000, Santiago-7, Chile
Search for other works by this author on:
Patricio BURDILES;
Patricio BURDILES
‡Department of Surgery, University of Chile Clinical Hospital, Casilla 70000, Santiago-7, Chile
Search for other works by this author on:
Juan C. DIAZ;
Juan C. DIAZ
‡Department of Surgery, University of Chile Clinical Hospital, Casilla 70000, Santiago-7, Chile
Search for other works by this author on:
Gladys SMOK;
Gladys SMOK
§Department of Pathological Anatomy, University of Chile Clinical Hospital, Casilla 70000, Santiago-7, Chile
Search for other works by this author on:
Lilian THIELEMANN;
Lilian THIELEMANN
∥Pathophysiology Program, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Casilla 70000, Santiago-7, Chile
Search for other works by this author on:
Jaime PONIACHIK
Jaime PONIACHIK
†Department of Medicine, University of Chile Clinical Hospital, Casilla 70000, Santiago-7, Chile
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
August 27 2003
Revision Received:
September 11 2003
Accepted:
October 14 2003
Accepted Manuscript online:
October 14 2003
Online ISSN: 1470-8736
Print ISSN: 0143-5221
© 2004 The Biochemical Society
2004
Clin Sci (Lond) (2004) 106 (3): 261–268.
Article history
Received:
August 27 2003
Revision Received:
September 11 2003
Accepted:
October 14 2003
Accepted Manuscript online:
October 14 2003
Connected Content
A commentary has been published:
Early biochemical observations point to nutritional strategies to manage non-alcoholic fatty liver disease
Citation
Luis A. VIDELA, Ramón RODRIGO, Myriam ORELLANA, Virginia FERNANDEZ, Gladys TAPIA, Luis QUIÑONES, Nelson VARELA, Jorge CONTRERAS, Raúl LAZARTE, Attila CSENDES, Jorge ROJAS, Fernando MALUENDA, Patricio BURDILES, Juan C. DIAZ, Gladys SMOK, Lilian THIELEMANN, Jaime PONIACHIK; Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients. Clin Sci (Lond) 1 March 2004; 106 (3): 261–268. doi: https://doi.org/10.1042/CS20030285
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |